Laserfiche WebLink
7. Epidemiological surveillance of OUD-related behaviors in critical populations, <br />including individuals entering the criminal justice system, including, but not limited <br />to approaches modeled on the Arrestee Drug Abuse Monitoring (*ADAM') system. <br />8. Qualitative and quantitative research regarding public health risks and harm reduction <br />opportunities within illicit drug markets, including surveys of market participants <br />who sell or distribute illicit opioids. <br />9. Geospatial analysis of access barriers to MAT and their association with treatment <br />engagement and treatment outcomes. <br />J-1 5